For the year ending 2025-12-31, CYTK has $1,424,537K in assets. $2,084,162K in debts. $122,518K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 122,518 | |||
| Short-term investments | 759,703 | |||
| Accounts receivable | 17,764 | |||
| Prepaid expenses and other current assets | 16,990 | |||
| Total current assets | 916,975 | |||
| Long-term investments | 335,048 | |||
| Total property and equipment | 126,495 | |||
| Less accumulated depreciation | 47,301 | |||
| Property and equipment, net | 79,194 | |||
| Operating lease right-of-use assets | 75,979 | |||
| Other assets | 17,341 | |||
| Total assets | 1,424,537 | |||
| Accounts payable | 22,337 | |||
| Accrued liabilities | 83,278 | |||
| Short-term operating lease liabilities | 19,111 | |||
| Current portion of convertible and long-term debt | 41,181 | |||
| Derivative liabilities measured at fair value | 31,100 | |||
| Deferred revenue | 1,612 | |||
| Other current liabilities | 3,833 | |||
| Total current liabilities | 202,452 | |||
| Term loans, net | 246,384 | |||
| Convertible notes, net | 869,597 | |||
| Liabilities related to revenue participation right purchase agreements, net | 520,559 | |||
| Long-term operating lease liabilities | 107,970 | |||
| Liabilities related to rpi transactions measured at fair value | 137,200 | |||
| Total liabilities | 2,084,162 | |||
| Common stock, 0.001 par value authorized 163,000,000 shares issued and outstanding 122,943,172 shares at december 31, 2025 and 118,209,139 shares at december 31, 2024 | 123 | |||
| Additional paid-in capital | 2,826,341 | |||
| Accumulated other comprehensive income | 630 | |||
| Accumulated deficit | -3,486,719 | |||
| Total stockholders' deficit | -659,625 | |||
| Total liabilities and stockholders' deficit | 1,424,537 | |||
CYTOKINETICS INC (CYTK)
CYTOKINETICS INC (CYTK)